Laurus Labs signed pact with Global Fund to supply ARV drugs

Pharma Laurus Labs of Hyderabad has signed an agreement with Global Fund, an organization working towards ending AIDS, tuberculosis and malaria as epidemics, for a period of three-and-a-half years. This agreement has a motive to supply Anti retro viral (ARV) combination medicine namely Tenofovir/ Lamivudine/ Dolutegravir of 300/300/50mg (TLD) in Sub Saharan African (SSA) region for treating HIV/AIDS in sub-Saharan Africa. Laurus Labs will have volume commitments from the Global Fund to increase the access for the HIV/AIDS treatment by meeting the unmet needs and helping people.